177 related articles for article (PubMed ID: 21751234)
1. HDAC inhibition promotes cardiogenesis and the survival of embryonic stem cells through proteasome-dependent pathway.
Chen HP; Denicola M; Qin X; Zhao Y; Zhang L; Long XL; Zhuang S; Liu PY; Zhao TC
J Cell Biochem; 2011 Nov; 112(11):3246-55. PubMed ID: 21751234
[TBL] [Abstract][Full Text] [Related]
2. HDAC4 degradation mediates HDAC inhibition-induced protective effects against hypoxia/reoxygenation injury.
Du J; Zhang L; Zhuang S; Qin GJ; Zhao TC
J Cell Physiol; 2015 Jun; 230(6):1321-31. PubMed ID: 25475100
[TBL] [Abstract][Full Text] [Related]
3. HDAC activity regulates entry of mesoderm cells into the cardiac muscle lineage.
Karamboulas C; Swedani A; Ward C; Al-Madhoun AS; Wilton S; Boisvenue S; Ridgeway AG; Skerjanc IS
J Cell Sci; 2006 Oct; 119(Pt 20):4305-14. PubMed ID: 17038545
[TBL] [Abstract][Full Text] [Related]
4. Trichostatin a promotes cardiomyocyte differentiation of rat mesenchymal stem cells after 5-azacytidine induction or during coculture with neonatal cardiomyocytes via a mechanism independent of histone deacetylase inhibition.
Yang G; Tian J; Feng C; Zhao LL; Liu Z; Zhu J
Cell Transplant; 2012; 21(5):985-96. PubMed ID: 21944777
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation.
Borbone E; Berlingieri MT; De Bellis F; Nebbioso A; Chiappetta G; Mai A; Altucci L; Fusco A
Oncogene; 2010 Jan; 29(1):105-16. PubMed ID: 19802013
[TBL] [Abstract][Full Text] [Related]
6. Cyclin-dependent kinase 9 forms a complex with GATA4 and is involved in the differentiation of mouse ES cells into cardiomyocytes.
Kaichi S; Takaya T; Morimoto T; Sunagawa Y; Kawamura T; Ono K; Shimatsu A; Baba S; Heike T; Nakahata T; Hasegawa K
J Cell Physiol; 2011 Jan; 226(1):248-54. PubMed ID: 20665673
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 4 promotes ubiquitin-dependent proteasomal degradation of Sp3 in SH-SY5Y cells treated with di(2-ethylhexyl)phthalate (DEHP), determining neuronal death.
Guida N; Laudati G; Galgani M; Santopaolo M; Montuori P; Triassi M; Di Renzo G; Canzoniero LM; Formisano L
Toxicol Appl Pharmacol; 2014 Oct; 280(1):190-8. PubMed ID: 25068794
[TBL] [Abstract][Full Text] [Related]
8. Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition.
Zhang LX; Zhao Y; Cheng G; Guo TL; Chin YE; Liu PY; Zhao TC
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2154-63. PubMed ID: 20382965
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor promotes differentiation of embryonic stem cells into neural cells in adherent monoculture.
Yao X; Zhang JR; Huang HR; Dai LC; Liu QJ; Zhang M
Chin Med J (Engl); 2010 Mar; 123(6):734-8. PubMed ID: 20368096
[TBL] [Abstract][Full Text] [Related]
10. Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide.
Chang J; Varghese DS; Gillam MC; Peyton M; Modi B; Schiltz RL; Girard L; Martinez ED
Br J Cancer; 2012 Jan; 106(1):116-25. PubMed ID: 22158273
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo.
Singh T; Prasad R; Katiyar SK
Epigenetics; 2013 Jan; 8(1):54-65. PubMed ID: 23221619
[TBL] [Abstract][Full Text] [Related]
12. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis.
Zhang L; Qin X; Zhao Y; Fast L; Zhuang S; Liu P; Cheng G; Zhao TC
J Pharmacol Exp Ther; 2012 Apr; 341(1):285-93. PubMed ID: 22271820
[TBL] [Abstract][Full Text] [Related]
14. gp-91 mediates histone deacetylase inhibition-induced cardioprotection.
Zhao TC; Zhang LX; Cheng G; Liu JT
Biochim Biophys Acta; 2010 Jul; 1803(7):872-80. PubMed ID: 20433879
[TBL] [Abstract][Full Text] [Related]
15. Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation.
Culley KL; Hui W; Barter MJ; Davidson RK; Swingler TE; Destrument AP; Scott JL; Donell ST; Fenwick S; Rowan AD; Young DA; Clark IM
Arthritis Rheum; 2013 Jul; 65(7):1822-30. PubMed ID: 23575963
[TBL] [Abstract][Full Text] [Related]
16. HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha.
Place RF; Noonan EJ; Giardina C
Biochem Pharmacol; 2005 Aug; 70(3):394-406. PubMed ID: 15950952
[TBL] [Abstract][Full Text] [Related]
17. Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages.
Rahman MM; Kukita A; Kukita T; Shobuike T; Nakamura T; Kohashi O
Blood; 2003 May; 101(9):3451-9. PubMed ID: 12511413
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibition-mediated neuronal differentiation via the Wnt signaling pathway in human adipose tissue-derived mesenchymal stem cells.
Jang S; Jeong HS
Neurosci Lett; 2018 Mar; 668():24-30. PubMed ID: 29307599
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE
Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of histone deacetylase-induced myocardial repair is mediated by c-kit in infarcted hearts.
Zhang L; Chen B; Zhao Y; Dubielecka PM; Wei L; Qin GJ; Chin YE; Wang Y; Zhao TC
J Biol Chem; 2012 Nov; 287(47):39338-48. PubMed ID: 23024362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
